Steven M. Goldman, Director at Dova Pharmaceuticals, Inc. (DOVA), bought 5,000 shares at $19.64 ($98K) on 2017-07-05, disclosed to the SEC on 2017-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| DOVA | BUY | 2017-08-17 | $897K | — | Filing → |
| CNOB | BUY | 2014-02-06 | $111K | — | Filing → |
| CNOB | BUY | 2014-02-04 | $46K | — | Filing → |